Autonomix Medical Inc.
NASDAQ
Closed
Jul 29, 2026
Day's Range
3.9452 wk Range
0.2000Key Statistics
Symbol
AMIX
Name
Autonomix Medical Inc.
Currency
USD
Exchange
NASDAQ
High
7.21
Low
3.94
Open
‪4.32‬
Last
‪4.45‬
Market Cap
1.49M
Volume
3.80M
Average Volume
1.38M
Dividend Yield
‪0.00%‬
Change
1.70
Percent Change
61.82
Timestamp
2026-07-29
Close
4.45
Today Range Start
‪3.94‬
Today Range End
‪7.21‬
52 Week Range Start
‪0.2000‬
52 Week Range End
‪8.21‬
Type
Stocks
Country
United States
Compliance - AMIX - Autonomix Medical Inc.
Compliance
Status
COMPLIANT
Report Date
2025-02-18
Business Screen
COMPLIANT
Financial Screen
COMPLIANT
Compliant Revenue
‪99.00%‬
Non Compliant Revenue
‪0.00%‬
Questionable Revenue
‪1.00%‬
Securities To Market Cap Ratio
‪1.00%‬
Debt To Market Cap Ratio
‪3.00%‬
Historical Data - AMIX - Autonomix Medical Inc.
Historical Data
Market Cap - AMIX - Autonomix Medical Inc.
Market Cap
2026-07-28
1.49M
2026-07-27
1.51M
2026-07-24
1.58M
2026-07-23
1.90M
2026-07-22
2.16M
2026-07-21
2.32M
2026-07-20
2.29M
2026-07-17
2.41M
2026-07-16
2.67M
2026-07-15
2.78M
Splits - AMIX - Autonomix Medical Inc.
Splits
2026-06-24
1-for-21 split (21)
Earnings - AMIX - Autonomix Medical Inc.
Earnings
Balance Sheet - AMIX - Autonomix Medical Inc.
Balance Sheet
Cash Flow - AMIX - Autonomix Medical Inc.
Cash Flow
Income Statement - AMIX - Autonomix Medical Inc.
Income Statement
Recommendations - AMIX - Autonomix Medical Inc.
Recommendations
Profile - AMIX - Autonomix Medical Inc.
Profile
Mic Code
XNCM
Sector
Healthcare
Industry
Medical Devices
Employees
8
Autonomix Medical Inc. is a medical device company developing precision nerve-targeted therapies to treat diseases involving the peripheral nervous system. Its first-in-class platform technology features a proprietary catheter-based microchip sensing array that detects and differentiates neural signals with ultra-high sensitivity and on-site data processing, surpassing existing technologies. This enables real-time identification of target nerves, followed by proprietary radio frequency ablation to precisely disable them, and verification of treatment efficacy in a minimally invasive transvascular procedure. Initially focused on pain management for pancreatic cancer patients, the platform addresses unmet needs in chronic pain by offering targeted denervation as an alternative to opioids or invasive methods. With potential applications across cardiology, hypertension, pulmonology, gastroenterology, and interventional pain management, Autonomix Medical Inc. equips physicians with innovative tools for accurate diagnosis and therapy. Headquartered in The Woodlands, Texas, the company advances this breakthrough system protected by a global intellectual property portfolio.
Profile Details
Type
Common Stock
Address
21 Waterway Avenue
City
The Woodlands
State
TX
Zip
77380
Country
United States
Phone
713 588 6150
